{"id":832495,"date":"2025-04-01T12:58:22","date_gmt":"2025-04-01T16:58:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/"},"modified":"2025-04-01T12:58:22","modified_gmt":"2025-04-01T16:58:22","slug":"update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/","title":{"rendered":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MORRISVILLE, N.C., April  01, 2025  (GLOBE NEWSWIRE) &#8212;  Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company\u2019s business at a fireside chat at the 24<sup>th<\/sup> Annual Needham Virtual Healthcare Conference\u00a0on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET.<\/p>\n<p>Access to a webcast of the presentation will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k3YrXoUnM5T7rwdbF634hwyR3Y56AK0GcsletCbzDmqBdhPji4sVEJ4Ovw7c3UwMZ5JW2fHXYIHIjuvLRj5f7Yp3pgMPv2hAkXAxZJI7ZQShony2Oepfcu2KKpcRAmDEujQAWplE4Q40PdrHNrskvd0cXPpoT-ceTUD4tKUmh9ngyl-BNk9a11hB1_3r4u7B\" rel=\"nofollow\" target=\"_blank\">https:\/\/liquidia.com\/investors\/events-and-presentations<\/a>.<\/p>\n<p>An archived, recorded version of the presentation will be available on Liquidia\u2019s website for at least 30 days following the event.\u00a0<\/p>\n<p>\n        <strong>About\u00a0Liquidia Corporation<\/strong><br \/>\n        <br \/>Liquidia Corporation\u00a0is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT<sup>\u00ae<\/sup>\u00a0Technology. PRINT enabled the creation of Liquidia\u2019s lead candidate, YUTREPIA\u2122 (treprostinil) inhalation powder, an investigational drug for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company is also developing L606, an investigational sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about\u00a0Liquidia, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a_DmdBiz-6UCiHdz7-0w19DG4JB4ORiar1k_stIPqbTmykVKYxXqN6za3z1QSpsU2ic_Ey1xfaNbLtFq-bEoLxRQtfBfILcj5sthoDxH3Q8=\" rel=\"nofollow\" target=\"_blank\">www.liquidia.com<\/a>.<\/p>\n<p>\n        <strong>Contact Information<\/strong>\n      <\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Jason Adair<br \/>Chief Business Officer<br \/>919.328.4350<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=olbAKnd5OFpBjmQFnnjeOzSiqB0DgMUPXkoJRbZ79rmXV-5SVzF3w2PD6LXwbPnVOZBVaNKNTu3Sc3wy6IMhbIW12ahrFT69prNbIvA7qCkQUtQbJYBm_kr2AcNSnhNK\" rel=\"nofollow\" target=\"_blank\">jason.adair@liquidia.com<\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Patrick Wallace<br \/>Director, Corporate Communications<br \/>919.328.4383<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uKUxqw3Xwg8ZQOlqbuoEWG9PCWwcoTiS3b7VXzD6w8wm1DGumAkkJ_1KvAWoJu2TEtjajXMpgbrZcwB5PkasPIAtHpY7sEFS9QCgvkpvo_LqTZJW8apvhNmPy1t4pPDKwp_ttuEBZEBGqJMEnUzf-EQ9vEXWbSpB7BdxzNzNoP2lrG2d5DKT31wPDAqO_bqrhI0pmf7pfNMI0siUC6CeLPXBV1xuPPK6Hvdr8Dx1m-SMu_rfLALPe8YAIJ9UHJzVMVQy-ApgCm1vWQ9dbE-lR706JlJb2aU9e7S0ZDmZNX7UdGqRdbBfH0eRKe06e0-u\" rel=\"nofollow\" target=\"_blank\">patrick.wallace@liquidia.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWYwMjA2NjAtNmFmNi00ZWYwLTg0Y2QtYjc0ODk1YTg2ZGIzLTEwOTYwMzEtMjAyNS0wNC0wMS1lbg==\/tiny\/Liquidia-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company\u2019s business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference\u00a0on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET. Access to a webcast of the presentation will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. An archived, recorded version of the presentation will be available on Liquidia\u2019s website for at least 30 days following the event.\u00a0 About\u00a0Liquidia Corporation Liquidia Corporation\u00a0is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-832495","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company\u2019s business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference\u00a0on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET. Access to a webcast of the presentation will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. An archived, recorded version of the presentation will be available on Liquidia\u2019s website for at least 30 days following the event.\u00a0 About\u00a0Liquidia Corporation Liquidia Corporation\u00a0is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the &hellip; Continue reading &quot;UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-01T16:58:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference\",\"datePublished\":\"2025-04-01T16:58:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/\"},\"wordCount\":248,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/\",\"name\":\"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\",\"datePublished\":\"2025-04-01T16:58:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk","og_description":"MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview of the company\u2019s business at a fireside chat at the 24th Annual Needham Virtual Healthcare Conference\u00a0on Wednesday, April 9, 2025, beginning at 8:45 a.m. ET. Access to a webcast of the presentation will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. An archived, recorded version of the presentation will be available on Liquidia\u2019s website for at least 30 days following the event.\u00a0 About\u00a0Liquidia Corporation Liquidia Corporation\u00a0is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the &hellip; Continue reading \"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-01T16:58:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference","datePublished":"2025-04-01T16:58:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/"},"wordCount":248,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/","name":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=","datePublished":"2025-04-01T16:58:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDkwNSM2ODQ1NTQ1IzIwODQ0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-liquidia-corporation-to-present-at-the-24th-annual-needham-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UPDATE \u2013 Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=832495"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832495\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=832495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=832495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=832495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}